HIV-1

Rachel P Galimidi1, Joshua S Klein1, Maria S Politzer1

  • 1Division of Biology and Biological Engineering, California Institute of Technology, 1200 East California Boulevard, Pasadena, CA 91125, USA.

Cell
|January 31, 2015
PubMed
概括

针对HIV-1 (人类免疫缺陷病毒1型) 的抗体由于病毒突变,效果较差. 工程双价抗体,在单个尖峰内结合显著提高中和功效.